secwatch.observer — SEC 8-K summary
======================================

Issuer:     Janux Therapeutics, Inc. (JANX)
CIK:        0001817713
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0000950170-21-001977
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Janux Therapeutics enters 126-month lease for ~47,300 sq ft lab/office space in San Diego
--------------------------------------------------------------------------------

- Lease for 47,300 sq ft at 10955 Vista Sorrento Pkwy, San Diego; commencement July 1, 2022.
- Base rent $271,952/month first year, with 6 months abated; 3% annual escalations thereafter.
- Tenant improvement allowance of ~$10.64 million from landlord.
- Letter of credit requirement of $815,856, reducible by 50% after 54 months.
- Term of 126 months; space for office, lab, vivarium, and R&D use.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817713/000095017021001977/0000950170-21-001977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817713/000095017021001977/janx-20211001.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-001977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer